New in -- our viewpoint on regulatory aspects of FDA's review of Covid19 vaccines and weighing benefits and risks.
"Does the #COVID19 vaccine work?" The answer will depend on the incidence and prevalence of infection, and the balance between magnitude of benefit and severity of (presumably rare) adverse effects
"Does the #COVID19 vaccine work?" will not be a simple yes/no but will depend on the prevalence of infection, and the balance between magnitude of benefit and severity of (presumably rare) adverse effects
PORTAL's own Dr. Jerry Avorn and discuss their recent policy work on #COVID19 #vaccines: (1) : (2) :
Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency via part of This is an important article by & Jerry Avorn. We need a strong regulatory response by based on strong science.
Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency by Avorn and
We need a rigorous approach to COVID-19 vaccines It would be a major public health misstep for premature rollout of vaccines before the planned trial data are even collected via part of